Rapport Therapeutics Balance Sheet (2023-2026) | RAPP

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter) 0.13M0.48M0.70M0.96M1.21M1.46M1.72M1.98M1.93M2.14M
Assets
Current Assets
Cash & Equivalents (Quarter) 79.53M159.41M70.17M74.27M110.16M39.31M56.80M57.60M260.40M513.00M52.65M78.06M63.61M
Receivables - Net (Quarter) 0.06M0.30M
Receivables (Quarter) 0.06M0.30M
Prepaid Assets (Quarter) 1.50M4.42M5.17M4.42M5.48M9.69M7.53M7.92M7.75M10.38M
Current Assets (Quarter) 150.87M340.67M325.94M309.80M290.97M270.24M520.66M498.56M484.69M446.86M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 1.92M3.47M3.41M3.53M3.40M3.17M3.12M2.98M2.52M2.34M
Other Non-Current Assets (Quarter) 0.55M0.19M0.19M0.16M0.21M1.03M1.07M0.98M1.06M1.06M
Non-Current Assets (Quarter) 4.55M5.43M5.21M5.13M11.09M15.25M14.66M13.87M12.90M12.13M
Assets (Quarter) 155.42M346.10M331.14M314.93M302.05M285.50M535.32M512.43M497.60M458.98M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 2.50M1.88M1.32M1.95M2.14M3.18M3.23M4.19M6.56M2.80M
Payables (Quarter) 2.50M1.88M1.32M1.95M2.14M3.18M3.23M4.19M6.56M2.80M
Accumulated Expenses (Quarter) 1.81M3.71M2.10M2.97M5.04M7.12M8.72M23.16M
Other Accumulated Expenses (Quarter) 0.11M0.37M0.28M0.47M0.32M0.07M0.10M0.01M0.14M0.22M
Current Leases (Quarter) 0.67M0.70M0.72M0.74M1.01M1.76M2.48M2.75M2.62M2.47M
Total Current Liabilities (Quarter) 8.80M8.10M7.10M8.77M9.38M11.88M14.32M19.05M17.90M28.42M
Non-Current Liabilities
Preferred Stock Liabilities (Quarter) 89.49M89.49M166.58M145.25M
Operating Leases (Quarter) 1.48M1.12M0.93M0.74M6.83M10.10M9.39M8.73M8.19M7.63M
Other Non-Current Liabilities (Quarter) 4.20M9.43M
Total Non-Current Liabilities (Quarter) 10.28M0.07M
Total Liabilities (Quarter) 14.48M9.21M8.03M9.51M16.22M21.98M23.71M27.78M26.09M36.06M
Shareholder's Equity
Common Equity (Quarter) -9.43M-13.12M-25.63M-39.63M336.89M323.11M305.43M285.84M263.51M511.62M484.65M471.51M422.93M
Liabilities and Shareholders Equity (Quarter) 155.42M346.10M331.14M314.93M302.05M285.50M535.32M512.43M497.60M458.98M
Treasury Shares (Quarter) 0.21M
Retained Earnings (Quarter) -311.70M